Author/Creator: Hamlin, P. John - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Hamlin, P. John

1. Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease—authors' reply. Issue 8 (27th September 2022)

Authors:: Fairbrass, Keeley M.; Hamlin, P. John; Gracie, David J.; Ford, Alexander C.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 56:Issue 8(2022)
Page Start:: 1302
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and tolerability of initiating, or switching to, infliximab biosimilar CT-P13 in inflammatory bowel disease (IBD): a large single-centre experience. (3rd June 2018)

Authors:: Ratnakumaran, Raguprakash; To, Natalie; Gracie, David J.; Selinger, Christian P.; O'Connor, Anthony; Clark, Tanya; Carey, Nicola; Leigh, Katherine; Bourner, Lynsey; Ford, Alexander C.; Hamlin, P. John
Journal:: Scandinavian journal of gastroenterology
Issue:: Volume 53:Number 6(2018)
Page Start:: 700
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin. (17th January 2018)

Authors:: Derwa, Yannick; Williams, Christopher J.M.; Sood, Ruchit; Mumtaz, Saqib; Bholah, M. Hassan; Selinger, Christian P.; Hamlin, P. John; Ford, Alexander C.; Gracie, David J.
Journal:: Therapeutic advances in gastroenterology
Issue:: Volume 11(2018)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease. Issue 12 (December 2017)

Authors:: Selinger, Christian P.; Lenti, Marco V.; Clark, Tanya; Rafferty, Helen; Gracie, David; Ford, Alexander C.; O'Connor, Anthony; Ahmad, Tariq; Hamlin, P. John
Journal:: Inflammatory bowel diseases
Issue:: Volume 23:Issue 12(2017)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Natural history and impact of irritable bowel syndrome‐type symptoms in inflammatory bowel disease during 6 years of longitudinal follow‐up. Issue 8 (22nd August 2022)

Authors:: Fairbrass, Keeley M.; Hamlin, P. John; Gracie, David J.; Ford, Alexander C.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 56:Issue 8(2022)
Page Start:: 1264
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Randomized controlled trial: a pilot study of a psychoeducational intervention for fatigue in patients with quiescent inflammatory bowel disease. (March 2019)

Authors:: O'Connor, Anthony; Ratnakumaran, Raguprakash; Warren, Lisa; Pullen, Debbie; Errington, Anna; Gracie, David J.; Sagar, Rebecca C.; Hamlin, P. John; Ford, Alexander C.
Journal:: Therapeutic advances in chronic disease
Issue:: Volume 10(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. The Effect of Antidepressants on the Course of Inflammatory Bowel Disease. (9th September 2018)

Authors:: Hall, Barry J.; Hamlin, P. John; Gracie, David J.; Ford, Alexander C.
Other Names:: Peltekian Kevork M. Academic Editor.
Journal:: Canadian journal of gastroenterology & hepatology
Issue:: Volume 2018(2018)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗